Research ArticleClinical Studies
The Prognostic Role of KRAS Mutation in Patients with Advanced NSCLC Treated with Second- or Third-line Chemotherapy
MARTIN SVATON, ONDREJ FIALA, MILOS PESEK, ZBYNEK BORTLICEK, MAREK MINARIK, LUCIE BENESOVA and ONDREJ TOPOLCAN
Anticancer Research March 2016, 36 (3) 1077-1082;